share_log

JMP Securities Reiterates Market Outperform on Cormedix, Maintains $19 Price Target

JMP Securities Reiterates Market Outperform on Cormedix, Maintains $19 Price Target

JMP Securities重申Cormedix的市场跑赢大盘,维持19美元的目标股价
Benzinga ·  2023/11/15 12:57

JMP Securities analyst Jason Butler reiterates Cormedix (NASDAQ:CRMD) with a Market Outperform and maintains $19 price target.

JMP Securities分析师杰森·巴特勒重申Cormedix(纳斯达克股票代码:CRMD)的股价跑赢大盘,维持19美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发